These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37743129)

  • 1. Functional imaging after the "ISCHEMIA" trial.
    Duhamel S; Pezel T; Garot J
    Arch Cardiovasc Dis; 2023 Nov; 116(11):529-534. PubMed ID: 37743129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Coronary Anatomy and Myocardial Ischemia on Long-Term Survival in Patients with Stable Ischemic Heart Disease.
    Weintraub WS; Hartigan PM; Mancini GBJ; Teo KK; Maron DJ; Spertus JA; Chaitman BR; Shaw LJ; Berman D; Boden WE
    Circ Cardiovasc Qual Outcomes; 2019 Feb; 12(2):e005079. PubMed ID: 30773025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized Comparison of Clinical Effectiveness of Pharmacologic SPECT and PET MPI in Symptomatic CAD Patients.
    Patel KK; Al Badarin F; Chan PS; Spertus JA; Courter S; Kennedy KF; Case JA; McGhie AI; Heller GV; Bateman TM
    JACC Cardiovasc Imaging; 2019 Sep; 12(9):1821-1831. PubMed ID: 31326480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Fractional Flow Reserve Derived From Coronary Computed Tomography Angiography on Heart Team Treatment Decision-Making in Patients With Multivessel Coronary Artery Disease: Insights From the SYNTAX III REVOLUTION Trial.
    Andreini D; Modolo R; Katagiri Y; Mushtaq S; Sonck J; Collet C; De Martini S; Roberto M; Tanaka K; Miyazaki Y; Czapla J; Schoors D; Plass A; Maisano F; Kaufmann P; Orry X; Metzdorf PA; Folliguet T; Färber G; Diamantis I; Schönweiß M; Bonalumi G; Guglielmo M; Ferrari C; Olivares P; Cavallotti L; Leal I; Lindeboom W; Onuma Y; Serruys PW; Bartorelli AL;
    Circ Cardiovasc Interv; 2019 Dec; 12(12):e007607. PubMed ID: 31833413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial.
    Hochman JS; Reynolds HR; Bangalore S; O'Brien SM; Alexander KP; Senior R; Boden WE; Stone GW; Goodman SG; Lopes RD; Lopez-Sendon J; White HD; Maggioni AP; Shaw LJ; Min JK; Picard MH; Berman DS; Chaitman BR; Mark DB; Spertus JA; Cyr DD; Bhargava B; Ruzyllo W; Wander GS; Chernyavskiy AM; Rosenberg YD; Maron DJ;
    JAMA Cardiol; 2019 Mar; 4(3):273-286. PubMed ID: 30810700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive FFR Derived From Coronary CT Angiography: Management and Outcomes in the PROMISE Trial.
    Lu MT; Ferencik M; Roberts RS; Lee KL; Ivanov A; Adami E; Mark DB; Jaffer FA; Leipsic JA; Douglas PS; Hoffmann U
    JACC Cardiovasc Imaging; 2017 Nov; 10(11):1350-1358. PubMed ID: 28412436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Cardiac CT With Myocardial Perfusion Imaging Versus Functional Testing in Suspected Coronary Artery Disease: The Multicenter, Randomized CRESCENT-II Trial.
    Lubbers M; Coenen A; Kofflard M; Bruning T; Kietselaer B; Galema T; Kock M; Niezen A; Das M; van Gent M; van den Bos EJ; van Woerkens L; Musters P; Kooij S; Nous F; Budde R; Hunink M; Nieman K
    JACC Cardiovasc Imaging; 2018 Nov; 11(11):1625-1636. PubMed ID: 29248657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiography is the gold standard and objective evidence of myocardial ischemia is mandatory if lesion severity is questionable. - Indication of PCI for angiographically significant coronary artery stenosis without objective evidence of myocardial ischemia (Pro)-.
    Nakamura M
    Circ J; 2011; 75(1):204-10; discussion 217. PubMed ID: 21173507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine learning assessment of myocardial ischemia using angiography: Development and retrospective validation.
    Hae H; Kang SJ; Kim WJ; Choi SY; Lee JG; Bae Y; Cho H; Yang DH; Kang JW; Lim TH; Lee CH; Kang DY; Lee PH; Ahn JM; Park DW; Lee SW; Kim YH; Lee CW; Park SW; Park SJ
    PLoS Med; 2018 Nov; 15(11):e1002693. PubMed ID: 30422987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): coronary anatomy versus ischemia.
    Mancini GBJ; Hartigan PM; Shaw LJ; Berman DS; Hayes SW; Bates ER; Maron DJ; Teo K; Sedlis SP; Chaitman BR; Weintraub WS; Spertus JA; Kostuk WJ; Dada M; Booth DC; Boden WE
    JACC Cardiovasc Interv; 2014 Feb; 7(2):195-201. PubMed ID: 24440015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What can we expect in PCI in patients with chronic coronary artery disease. - Indication of PCI for angiographically significant coronary artery stenosis without objective evidence of myocardial ischemia (Con)-.
    Akasaka T
    Circ J; 2011; 75(1):211-7; discussion 210. PubMed ID: 21173503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How atherosclerosis defines ischemia: Atherosclerosis quantification and characterization as a method for determining ischemia.
    Ahmadi A; Senoner T; Correa A; Feuchtner G; Narula J
    J Cardiovasc Comput Tomogr; 2020; 14(5):394-399. PubMed ID: 31776070
    [No Abstract]   [Full Text] [Related]  

  • 13. Ischemia change in stable coronary artery disease is an independent predictor of death and myocardial infarction.
    Farzaneh-Far A; Phillips HR; Shaw LK; Starr AZ; Fiuzat M; O'Connor CM; Sastry A; Shaw LJ; Borges-Neto S
    JACC Cardiovasc Imaging; 2012 Jul; 5(7):715-24. PubMed ID: 22789940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and Rationale of the RIPCORD 2 Trial (Does Routine Pressure Wire Assessment Influence Management Strategy at Coronary Angiography for Diagnosis of Chest Pain?): A Randomized Controlled Trial to Compare Routine Pressure Wire Assessment With Conventional Angiography in the Management of Patients With Coronary Artery Disease.
    Elguindy M; Stables R; Nicholas Z; Kemp I; Curzen N
    Circ Cardiovasc Qual Outcomes; 2018 Feb; 11(2):e004191. PubMed ID: 29449442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Routine Invasive Physiology at Time of Angiography in Patients With Multivessel Coronary Artery Disease on Reclassification of Revascularization Strategy: Results From the DEFINE REAL Study.
    Van Belle E; Gil R; Klauss V; Balghith M; Meuwissen M; Clerc J; Witzenbichler B; Cercek M; Vlachojannis M; Lang I; Commeau P; Vincent F; Testa L; Wasek W; Debry N; Kische S; Gabrielli G; Sardella G
    JACC Cardiovasc Interv; 2018 Feb; 11(4):354-365. PubMed ID: 29471949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac Computed Tomography for Comprehensive Coronary Assessment: Beyond Diagnosis of Anatomic Stenosis.
    Parikh R; Patel A; Lu B; Senapati A; Mahmarian J; Chang SM
    Methodist Debakey Cardiovasc J; 2020; 16(2):77-85. PubMed ID: 32670467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial Perfusion Imaging Versus Computed Tomography Angiography-Derived Fractional Flow Reserve Testing in Stable Patients With Intermediate-Range Coronary Lesions: Influence on Downstream Diagnostic Workflows and Invasive Angiography Findings.
    Nørgaard BL; Gormsen LC; Bøtker HE; Parner E; Nielsen LH; Mathiassen ON; Grove EL; Øvrehus KA; Gaur S; Leipsic J; Pedersen K; Terkelsen CJ; Christiansen EH; Kaltoft A; Mæng M; Kristensen SD; Krusell LR; Lassen JF; Jensen JM
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of Coronary Revascularization in Stable Angina: Comparison of FFR
    Rønnow Sand NP; Nissen L; Winther S; Petersen SE; Westra J; Christiansen EH; Larsen P; Holm NR; Isaksen C; Urbonaviciene G; Deibjerg L; Husain M; Thomsen KK; Rohold A; Bøtker HE; Bøttcher M
    JACC Cardiovasc Imaging; 2020 Apr; 13(4):994-1004. PubMed ID: 31422146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies in stable ischemic heart disease: lessons from the COURAGE and BARI-2D trials.
    Fernandez SF; Boden WE
    Curr Atheroscler Rep; 2010 Nov; 12(6):423-31. PubMed ID: 20845088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.
    Shaw LJ; Berman DS; Maron DJ; Mancini GB; Hayes SW; Hartigan PM; Weintraub WS; O'Rourke RA; Dada M; Spertus JA; Chaitman BR; Friedman J; Slomka P; Heller GV; Germano G; Gosselin G; Berger P; Kostuk WJ; Schwartz RG; Knudtson M; Veledar E; Bates ER; McCallister B; Teo KK; Boden WE;
    Circulation; 2008 Mar; 117(10):1283-91. PubMed ID: 18268144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.